Medicamen Biotech has informed that the Board of Directors at their meeting held today has allotted the 324000 Equity Shares, at a price of Rs 618 per share including premium of Rs 608 each ranking pari passu with the existing equity share holders of the Company.
The above information is a part of company’s filings submitted to BSE.